ApprovalTrail

Approval · Notice of Compliance 660 · 2002

IMODIUM ADVANCED: Notice of Compliance 660

Issued February 6, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
660
Date
February 6, 2002
Product type
Nonprescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New dosage form: caplets
Therapeutic class
Oral antidiarrheal, antiflatulent

Products in this notice

BrandDINStatus today
IMODIUM ADVANCED02245185Marketed

Medicinal ingredients